RVPH Institutional Ownership

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Latest close $0.43 as of Aug 6, 2026

Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.

Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.

Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Jul 31, 2026

Public consensus preview Reduction leaning 30/100 institutional research score

1 tracked institution Latest filing Jul 31, 2026

1 exited across 1 comparable institution.

Accumulating0

Unchanged0

Reducing0

Exited1

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$0.26 52-week high$17.20

Latest close $0.43 1.0% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Jun 30, 2026

UBS Group Jul 31, 2026 filed

Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 2 of 2 parsed filing(s)

Holder	Observed / filed	Reported change	Shares	Ownership	Observation	Filing	Latest
UBS Group CIK0001610520	Jun 30, 2026 observed Jul 31, 2026 filed · 31d Schedule 13G amendment	Exit below reporting threshold	0 -746.1K	0.00% -5.82 pts	$0.63	$0.44	$0.43
UBS Group CIK0001610520	Mar 31, 2026 observed May 7, 2026 filed · 37d Initial Schedule 13G	Initial Schedule 13G	746.1K	5.82%	$0.73	$0.86	$0.43

Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Recent multi-institution accumulation

TVTX Travere Therapeutics, Inc. 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026